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Figure 2 CT abdomen showing a new splenic lesion.
Figure 1 CTabdomen showing nodules in the spleen and liver.We report the case of a Malay boy with acute lymphoblastic
leukemia who had disseminated Fusarium spp. infection
affecting the liver and spleen. He was treated with vorico-
nazole for four months. At the end of this time, there were
new lesions in the spleen. His parents were counseled for
splenectomy, but they refused and subsequently absconded.
Human infection with Fusarium spp. is increasingly
reported, especially in the immunocompromised population.
The majority of patients have disseminated disease, com-
monly affecting the skin, lungs and sinuses.1
A three-year-old Malay boy was diagnosed with acute
lymphoblastic leukemia. He was febrile and neutropenic at
presentation, and a blood culture on day 8 grew Fusarium
spp. He had no skin lesions and ophthalmological examination
was also normal. A computed tomographic (CT) scan of his
sinuses and chest was clear. However, a CT scan of the
abdomen revealed nodules in the spleen and liver
(Figure 1). He was initially treated with amphotericin B,
but the fever failed to abate. He was then started on
voriconazole and the fever settled. He received a total of1201-9712/$36.00
doi:10.1016/j.ijid.2008.10.003three weeks intravenous and three months oral voriconazole.
During this time, his leukemia was in remission and he
continued to receive chemotherapy. At the end of four
months of anti-fungal therapy, a repeat CT scan of the abdo-
men showed new splenic nodules (Figure 2). At this stage,
there was no fever and the child was not neutropenic. The
option of splenectomy was discussed with the child’s parents.
Unfortunately, they declined and subsequently absconded,
refusing further treatment or follow-up.
Disseminated Fusarium spp. infection is a disease with a
high mortality.2 This fungus shows variable susceptibility to
amphotericin B, but has been reported to respond well to
voriconazole.3 Our patient showed an initial good response to
voriconazole, but still had new lesions despite four months of
therapy. Splenectomy is an important adjunct in the manage-
ment of splenic abscesses in immunocompromised patients,
especially when medical treatment has failed.4 The clinical
picture in our case resembles that of hepatosplenic candi-
diasis; splenectomy has been shown to be curative for this
condition.5 In young children under the age of five years,
e334 Medical imagerythere is an increased risk of bacterial infections post-
splenectomy, so the risks and benefits need to be weighed.
In developing countries, absconding treatment is a common
problem that hampers patient management.
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